Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer
Head and neck cancers (HNC) are a biologically diverse set of cancers that are responsible for over 660,000 new diagnoses each year. Current therapies for HNC require a comprehensive, multimodal approach encompassing resection, radiation therapy, and systemic therapy. With an increased understanding...
Main Authors: | Hänel W. Eberly, Bao Y. Sciscent, F. Jeffrey Lorenz, Eleni M. Rettig, Neerav Goyal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/12/2/415 |
Similar Items
-
The Role of Biomarkers in HPV-Positive Head and Neck Squamous Cell Carcinoma: Towards Precision Medicine
by: Antea Krsek, et al.
Published: (2024-07-01) -
De-Escalated Therapy and Early Treatment of Recurrences in HPV-Associated Head and Neck Cancer: The Potential for Biomarkers to Revolutionize Personalized Therapy
by: Wendell G. Yarbrough, et al.
Published: (2024-03-01) -
Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma
by: Qimin Zhou, et al.
Published: (2022-11-01) -
The Next Chapter in Cancer Diagnostics: Advances in HPV-Positive Head and Neck Cancer
by: Antea Krsek, et al.
Published: (2024-07-01) -
Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck
by: Eiichi Sasaki, et al.
Published: (2020-04-01)